Experience with New Clotting Products in the Treatment of Hemophilia-Related Bleeding Episodes
Factor concentrate products have changed significantly over the last decade. Efficacy of concentrates has been very good with adequate hemostasis being achieved utilizing most concentrates. However, two issues have emerged regarding concentrates, their safety, that is freedom from transfusion transmitted viruses, and their purity. Newer products are now available that are both much safer and highly pure.
Unable to display preview. Download preview PDF.